Sunshine Biopharma (SBFM) said Monday its Canadian unit Nora Pharma has launched a generic version of Everolimus in Canada.
The company said the drug is a substitute for Afinitor and is used to treat certain types of cancer, including advanced kidney cancer, certain breast cancers, and specific neuroendocrine tumors.
The product is available in 2.5 mg, 5 mg, and 10 mg tablet doses, Sunshine said.
Shares of the company were up more than 16% in recent Monday premarket activity.
Price: 1.46, Change: +0.21, Percent Change: +16.84
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.